OCTIQ LUBRICANT EYE DROPS- dextran 70 hypromellose solution/ drops 
Innovus Pharmaceuticals, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Octiq Lubricant Eye  Drops

Active ingredients

Dextran 70 0.1%

Hypromellose 2910 0.3%

Purpose

Lubricant

Lubricant

Uses

Warnings

For external use only

Do not use

When using this product

Stop use and ask a doctor if

Keep out of reach of children 

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other Information 

Inactive ingredients

Boric acid, disodium edetate, potassium chloride, povidone, purified water, sodium borate, sodium chloride
Preservative added: benzalkonium choride

Questions?

Call 1.800.996.5122

(Mon-Fri 9AM-5PM EST)

image description

OCTIQ LUBRICANT EYE DROPS 
dextran 70 hypromellose solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:57483-610
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DEXTRAN 70 (UNII: 7SA290YK68) (DEXTRAN 70 - UNII:7SA290YK68) DEXTRAN 701 mg  in 1 mL
HYPROMELLOSE 2910 (4000 MPA.S) (UNII: RN3152OP35) (HYPROMELLOSE 2910 (4000 MPA.S) - UNII:RN3152OP35) HYPROMELLOSE 2910 (4000 MPA.S)3 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BORIC ACID (UNII: R57ZHV85D4)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
POTASSIUM CHLORIDE (UNII: 660YQ98I10)  
POVIDONE (UNII: FZ989GH94E)  
WATER (UNII: 059QF0KO0R)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57483-610-152 in 1 CARTON11/14/2021
115 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34911/14/2021
Labeler - Innovus Pharmaceuticals, Inc. (962507187)
Establishment
NameAddressID/FEIBusiness Operations
AMMAN PHARMACEUTICAL INDUSTRIES534677849manufacture(57483-610)

Revised: 12/2022
Document Id: 3d565185-d750-400a-bcf7-dd6a3d29d282
Set id: 407eeffb-cb32-44bc-aef4-b1b654ac6159
Version: 2
Effective Time: 20221231
 
Innovus Pharmaceuticals, Inc.